GlassScriptPhysician profile
John H Spina
NPI 1265425144
$1,187.26
in general payments reported to CMS, 2019-2025
7 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2023: $196 · 2024: $477 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $268.50 | 2019-2025 | Grafix Pl |
| Abbott Laboratories | $250.04 | 2024-2025 | Esprit, Diamondback Peripheral |
| Angiodynamics, INC. | $179.98 | 2024 | Auryon Laser System 100-120 Vac |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.65 | 2023 | Jublia |
| Kerecis Limited | $128.33 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $111.51 | 2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $100.25 | 2024 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Spina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.